Theratechnologies Inc. (TSE:TH - Get Free Report) shot up 29.9% on Wednesday . The company traded as high as C$2.99 and last traded at C$2.87. 168,744 shares traded hands during trading, an increase of 248% from the average session volume of 48,537 shares. The stock had previously closed at C$2.21.
Analyst Upgrades and Downgrades
Separately, Research Capitl upgraded Theratechnologies to a "strong-buy" rating in a report on Friday, February 14th.
Get Our Latest Stock Report on Theratechnologies
Theratechnologies Trading Down 6.7 %
The company has a debt-to-equity ratio of -293.92, a quick ratio of 0.64 and a current ratio of 1.08. The company has a market capitalization of C$70.83 million, a P/E ratio of -25.13, a P/E/G ratio of -8.50 and a beta of 1.73. The company has a 50-day simple moving average of C$2.35 and a 200 day simple moving average of C$2.11.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Featured Stories
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
